Similar articles

• Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.

  Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS. Wong SN, et al. Liver Transpl. 2007 Mar;13(3):334-42. doi: 10.1002/lt.20959. Liver Transpl. 2007. PMID: 17154401
• Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

  Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU. Yi NJ, et al. Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606. Liver Transpl. 2009. PMID: 19399732
• Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?

  Yao FY, Roberts JP. Yao FY, et al. Liver Transpl. 2004 Jul;10(7):919-21. doi: 10.1002/lt.20190. Liver Transpl. 2004. PMID: 15237378 No abstract available.
• Surgical management of hepatocellular carcinoma.

  Lotze MT. Lotze MT. Gastroenterol Clin North Am. 1987 Dec;16(4):613-26. Gastroenterol Clin North Am. 1987. PMID: 2831154 Review.
• Liver transplantation for hepatocellular carcinoma: how far can we push the envelope?

  Tan KC. Tan KC. Singapore Med J. 2003 Jun;44(6):309-11. Singapore Med J. 2003. PMID: 14560865 Review. No abstract available.